decisionhealth Newsletters, Part B News - 2008 Issue 4 (April)
CMS introduces new HCPCS for Albuterol, Levalbuterol
Subscribe or sign in to view the full article.
Article Overview
This article covers CMS’s April 1 HCPCS changes for selected asthma and other injectable drugs, including new and discontinued temporary billing codes, along with brief reporting guidance on denials and payer follow-up. It is relevant to coders, billing staff, and revenue cycle professionals who handle Medicare and other payer claims for these drug products.
Why This Topic Matters
It helps billing and coding teams identify which HCPCS drug codes were updated, retired, or newly assigned so claims can be aligned with CMS guidance and denial follow-up can be directed appropriately.
Article Sections
-
HCPCS code changes effective April 1
Summarizes the CMS update affecting drug billing codes effective April 1 and presents the affected products and related code changes.
-
Carrier and CMS follow-up guidance
Describes the general steps CMS suggests when claims are denied despite use of the updated HCPCS codes.
What You Will Learn
- Which HCPCS drug code updates are discussed in the CMS notice
- What types of products are affected by the April 1 changes
- How the article frames denial follow-up with carriers and CMS regional offices
- Which broad billing categories are involved in the code changes
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle personnel
- DME/drug claims billers
- Practice managers
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com